Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent-Reference-Cited by-同舟云学术

Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent

Published:2015-07 Issue:13 Volume:23 Page:3436-3447
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Czopek Anna,Kołaczkowski Marcin,Bucki Adam,Byrtus Hanna,Pawłowski Maciej,Kazek Grzegorz,Bojarski Andrzej J.,Piaskowska Agata,Kalinowska-Tłuścik Justyna,Partyka Anna,Wesołowska Anna

Funder

National Science Center

European Regional Development Fund

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference55 articles.

1. Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors: Design, Synthesis, and Effects on Behavior

2. Schizophrenia

3. Dopamine Modulation of Emotional Processing in Cortical and Subcortical Neural Circuits: Evidence for a Final Common Pathway in Schizophrenia?

4. Do we still believe in the dopamine hypothesis? New data bring new evidence

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crystallographic and theoretical analysis of a spirohydantoin derivative: 3-(4‑tert-butylbenzoyl)-1,3-diazaspiro[4.5]decane-2,4‑dione;Journal of Molecular Structure;2024-08

2. QSRR Modeling of Lipophilicity of New Spirohydantoin Derivatives Determined with Various TLC Systems;Acta Chimica Slovenica;2024-06-20

3. Chromatographic characterization of new spirohydantoins derived from β-tetralone;Journal of Liquid Chromatography & Related Technologies;2024-01-10

4. Novel Lipophilic Hydroxamates Based on Spirocarbocyclic Hydantoin Scaffolds with Potent Antiviral and Trypanocidal Activity;Pharmaceuticals;2023-07-24

5. Advances in the discovery of new chemotypes through ultra-large library docking;Expert Opinion on Drug Discovery;2023-02-02